Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience Raises $33M

NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has raised $33 million in private financing. To date, the company has raised $166 million.

"We welcome the additional equity capital to further accelerate growth of the core gene synthesis business, as well as pharmaceutical discovery and data storage vertical strategies," Twist CEO Emily Leproust said in a statement.

Twist offers synthetic DNA manufacturing services for genes, oligonucleotide pools, and variant libraries, and is developing methods to use DNA for data storage. The company is currently involved in a lawsuit with Agilent Technologies, which alleges that Twist and certain executives stole genomics technology. Twist has denied the charges.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.